Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia (CAH) is a group of autosomal recessive disorders characterized by enzymatic defects in the adrenal steroidogenesis pathway. This leads to impaired cortisol production, compensatory overproduction of adrenocorticotropic hormone (ACTH), and subsequent bilateral adrenal cortical hyperplasia with androgen excess.

CAH is caused by loss-of-function mutations in genes encoding steroidogenic enzymes. Over 90% of cases result from mutations in the CYP21A2 gene, causing 21-hydroxylase deficiency. Rarer causes include mutations in CYP11B1 (11-beta-hydroxylase), CYP17A1 (17-alpha-hydroxylase), and HSD3B2 (3-beta-hydroxysteroid dehydrogenase).

Impaired 21-hydroxylase activity prevents the conversion of 17-hydroxyprogesterone (17-OHP) to 11-deoxycortisol (and progesterone to deoxycorticosterone). The lack of cortisol eliminates negative feedback on the hypothalamus and pituitary, driving high ACTH secretion. Excessive ACTH stimulates the adrenal cortex, shunting precursor steroids into the androgen pathway, leading to excess testosterone and adrenal hyperplasia. Mineralocorticoid synthesis is also impaired in the "salt-wasting" classic form.

• Classic CAH: Prevails in approximately 1 in 14,000 to 1 in 15,000 live births globally.
• Non-classic CAH: Significantly more common, affecting ~1 in 1,000 individuals (higher in Ashkenazi Jewish populations).
• Gender/Age: Present at birth; equal genetic distribution between males and females.

• Consanguinity
• Family history of CAH or unexplained neonatal deaths
• Ashkenazi Jewish, Mediterranean, or Hispanic ancestry (for non-classic CAH)

• Vitals: Hypotension, tachycardia, or hypothermia (during adrenal crisis).
• Inspection: Hyperpigmentation of skin creases/scrotum (due to high ACTH), virilized external female genitalia (Prader staging I-V), or precocious pubertal development.
• Palpation: Impalpable gonads in virilized infants (suggesting female genotype), or palpable testicular masses (TARTs).

• A. Clinical Assessment: Evaluation of external genitalia and hydration state.
• B. Laboratory Testing: Key marker is 17-hydroxyprogesterone.
• C. Imaging Studies: Adrenal ultrasound to assess hyperplasia.
• D. Functional Tests: ACTH stimulation test (cosyntropin test).
• E. Biopsy Findings: Rarely indicated.

• G. Differential Diagnosis: Exclude other causes of ambiguous genitalia or virilization.

17-Hydroxyprogesterone (17-OHP)

• Type: Blood Test


• Purpose: Screen and diagnose 21-hydroxylase deficiency.


• Expected Findings: Highly elevated (>10,000 ng/dL in classic CAH).


• Interpretation: Elevated levels confirm a block in 21-hydroxylation. Serum Electrolytes


• Type: Blood Test


• Purpose: Evaluate aldosterone function and crisis risk.


• Expected Findings: Hyponatremia (low sodium) and hyperkalemia (high potassium).


• Interpretation: Indicates aldosterone deficiency (salt-wasting phenotype).

• Pelvic/Adrenal Ultrasound: Used to identify internal female reproductive structures (uterus/vagina) in ambiguous genitalia and evaluate adrenal size. Adrenal glands typically show bilateral enlargement.
• Bone Age X-ray: Done on the left hand/wrist to evaluate skeletal maturity; typical findings show advanced bone age relative to chronological age.

• Polycystic Ovary Syndrome (PCOS): Presents with hirsutism/irregular menses but lacks markedly elevated 17-OHP.
• Androgen-secreting tumors: Sudden onset of severe virilization with asymmetric adrenal/ovarian mass.
• Bilateral Renal Artery Stenosis: Causes electrolyte imbalances but normal steroid profile.

• Acute adrenal crisis (life-threatening shock)
• Short adult stature due to premature epiphyseal fusion
• Obesity, insulin resistance, and osteoporosis from glucocorticoid over-replacement
• Gender dysphoria in virilized females

With early diagnosis and lifelong adherence to hormone replacement, individuals have a normal life expectancy. Adult height may be slightly reduced, and fertility rates are lower but manageable.

• Carrier screening for high-risk families.
• Prenatal dexamethasone therapy (experimental, controversial due to side effects).

The following homeopathic remedies have been historically indicated for symptoms associated with Congenital Adrenal Hyperplasia. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Advanced Kidney & Renal Function Analyzer

Comprehensive nephrology panel. Calculates eGFR (CKD-EPI 2021 formula), CKD Stage, BUN/Creatinine Ratio, and Creatinine Clearance (Cockcroft-Gault) from a single lab panel.